Toronto, Ontario – October 7, 2008 - VisualSonics announced today the launch of the Vevo 2100 micro imaging ultrasound platform that will drive ultrasound use in pre clinical imaging to a new level and will transform high resolution clinical ultrasound imaging.
(ALEXANDRIA, VA) April 29, 2008 – Oxford Finance Corporation, the principal lender, and Comerica Bank, today announced they have finalized a $15 million senior secured loan agreement with VisualSonics Inc. Both financial institutions are established providers of senior debt to the life science community.
Toronto, Canada, October 25, 2007 - VisualSonics would like to congratulate Dr. Andrej Lyshchik and Dr. John Gore of Vanderbilt University Medical Center, Nashville, Tennessee, whose paper using the Vevo 770 and MicroMarker Contrast Agents, was selected as the cover paper for the November 2007 issue of the Journal of Ultrasound in Medicine.
Toronto, Ontario, March 16, 2007 – VisualSonics has been awarded the Best Customer Value” Award by Frost & Sullivan for its Vevo 770® micro-ultrasound system for preclinical research.
Toronto, Ontario, December 13, 2006 – In support of its growing sales efforts globally, VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, announced Larry McDowell has joined the company as Vice President, Sales.
Calgary, Alberta– September 29, 2006 – In recognition of his innovative concept of micro-ultrasound and its contribution to field of preclinical micro-imaging, Dr. Stuart Foster has won the 2006 Ernest C. Manning Awards Foundation’s “Award of Distinction”.
September 1, 2006 - VisualSonics Inc., the leading manufacturer of high-resolution micro-ultrasound systems, was profiled in the September 2006 issue of Genetic Engineering News (www.genengnews.com)
Toronto, Canada / Geneva, Switzerland - June 7, 2006 - VisualSonics (Toronto), the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, and Bracco Group, the foremost developer and manufacturer of ultrasound-based contrast agents, today announced an exclusive agreement for the joint development and manufacture of MicroMarker™ contrast agents.
VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, announced today targeted molecular imaging capabilities for its Vevo 770™ system making the platform even more powerful and quantitative for cancer researchers.
Toronto, Ontario. – March 9, 2006 – VisualSonics, the world’s only developer of high-resolution, ultrasound-based micro-imaging systems, announced today new cardiovascular functionalities for its Vevo 770™ high-resolution micro-ultrasound system making the platform more powerful and quantitative for cardiovascular researchers.